Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol
Authors:
Open Access
- 1 January 2020
- journal article
- research article
- Published by Elsevier in Contraception: X
- Vol. 2, 100023
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Telemedicine for medication abortionContraception, 2019
- TelAbortion: evaluation of a direct to patient telemedicine abortion service in the United StatesContraception, 2019
- Medical AbortionJournal of Obstetrics and Gynaecology Canada, 2016
- The feasibility of offering medical abortions by telemedicine: 20 months of experienceContraception, 2014
- Women's and Providers' Experiences with Medical Abortion Provided Through Telemedicine: A Qualitative StudyWomen's Health Issues, 2013
- Regional differences in surgical intervention following medical termination of pregnancy provided by telemedicineActa Obstetricia et Gynecologica Scandinavica, 2011
- Effectiveness and Acceptability of Medical Abortion Provided Through TelemedicineObstetrics & Gynecology, 2011
- Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe servicesBJOG: An International Journal of Obstetrics & Gynaecology, 2008
- Comparison of four regimens of misoprostol after methotrexate for early abortionInternational Journal of Gynecology & Obstetrics, 2008
- Regimens of misoprostol with mifepristone for early medical abortion: a randomised trialBJOG: An International Journal of Obstetrics & Gynaecology, 2006